Li Shi, Yu Zhe, Chen San-San, Li Fei, Lei Cheng-Yong, Chen Xing-Xing, Bao Ji-Ming, Luo Yang, Lin Guang-Zheng, Pang Shi-Yu, Tan Wan-Long
Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, P.R. China.
Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, P.R. China.
Urol Oncol. 2015 Oct;33(10):427.e1-10. doi: 10.1016/j.urolonc.2015.06.003. Epub 2015 Jul 9.
Yes-associated protein 1 (YAP1) and long noncoding RNA H19 act as potent oncogenes in many human cancers, but little is known about their roles in bladder cancer or their relationship with each other.
Quantitative real-time polymerase chain reaction and western blotting were performed retrospectively on human bladder cancer specimens and on bladder cancer cell lines (UMUC-3, EJ, and 5637). YAP1 and H19 expression levels were detected and correlated with clinical and pathologic grades. To determine whether YAP1 regulates H19 expression, their genes were overexpressed or suppressed in 5637 and UMUC-3 cells. The effects of YAP1/H19 on proliferation and migration were determined by viability, colony formation, transwell migration, and wound-healing assays.
YAP1 and H19 expression levels were markedly elevated in bladder cancer tissues and cells, and H19 expression was found to be significantly associated with YAP1 expression. Determination of their clinicopathologic significance in 40 human bladder cancer tissues showed that specimens in which YAP1 and H19 were overexpressed were associated with poorer clinicopathologic prognosis. In addition, YAP1 was found to enhance H19 expression, whereas H19 had no significant effect on YAP1 expression in bladder cancer cells. Furthermore, the results of in vitro analyses suggested that this association regulates cell proliferation and migration.
Our results emphasize the importance of YAP1 and H19 in bladder cancer progression and indicate that H19, at least in part, is induced by YAP1 overexpression.
Yes相关蛋白1(YAP1)和长链非编码RNA H19在许多人类癌症中作为强效癌基因发挥作用,但它们在膀胱癌中的作用或彼此之间的关系鲜为人知。
对人类膀胱癌标本和膀胱癌细胞系(UMUC-3、EJ和5637)进行回顾性定量实时聚合酶链反应和蛋白质印迹分析。检测YAP1和H19的表达水平,并将其与临床和病理分级相关联。为了确定YAP1是否调节H19的表达,在5637和UMUC-3细胞中对它们的基因进行过表达或抑制。通过活力、集落形成、Transwell迁移和伤口愈合试验确定YAP1/H19对增殖和迁移的影响。
YAP1和H19的表达水平在膀胱癌组织和细胞中显著升高,并且发现H19的表达与YAP1的表达显著相关。对40例人类膀胱癌组织进行临床病理意义测定,结果显示YAP1和H19过表达的标本与较差的临床病理预后相关。此外,发现YAP1增强H19的表达,而H19对膀胱癌细胞中YAP1的表达没有显著影响。此外,体外分析结果表明这种关联调节细胞增殖和迁移。
我们的结果强调了YAP1和H19在膀胱癌进展中的重要性,并表明H19至少部分是由YAP1过表达诱导的。